Laboratorios Farmaceuticos ROVI SA LABFF:OTCPK

RT Quote | Exchange | USD
Last | 12/01/20 EST
49.58UNCH (UNCH)
52 week range
49.58 - 49.58

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close49.58
  • 52 Week High49.58
  • 52 Week High Date12/01/20
  • 52 Week Low49.58
  • 52 Week Low Date12/01/20
  • Market Cap3,089.38M
  • Shares Out55.4M
  • 10 Day Average Volume-
  • Dividend0.21
  • Dividend Yield0.43%
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)1.35
  • P/E (TTM)36.83
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Laboratorios Farmaceuticos ROVI SA News

There is no recent news for this security.

Latest LABFF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor...
Juan Lopez-Belmonte Lopez
Chairman
Javier Lopez-Belmonte Encina
Vice Chairman
Ivan Jorge Lopez-Belmonte Encina
Vice Chairman
Juan Lopez-Belmonte Encina
Chief Executive Officer
Address
C/ Julian Camarillo, 35
Madrid, MAD
28037
Spain